Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-04-19

Clinical Trial Update: Combination Treatment for Advanced Liver Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating a combination therapy for advanced hepatocellular carcinoma, including cases with hepatic portal vein tumor invasion, has be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Hepatocellular Carcinoma, Hepatic Portal Vein Tumor Invasion | Phase 3 | Status: WITHDRAWN